Priming with a simplified intradermal HIV-1 DNA vaccine regimen followed by boosting with recombinant HIV-1 MVA vaccine is safe and immunogenic: a phase IIa randomized clinical trial (Q35431516)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Priming with a simplified intradermal HIV-1 DNA vaccine regimen followed by boosting with recombinant HIV-1 MVA vaccine is safe and immunogenic: a phase IIa randomized clinical trial |
scientific article |
Statements
1 reference
Priming with a simplified intradermal HIV-1 DNA vaccine regimen followed by boosting with recombinant HIV-1 MVA vaccine is safe and immunogenic: a phase IIa randomized clinical trial (English)
1 reference
Bernard Moss
1 reference
Said Aboud
1 reference
Michael Hoelscher
1 reference
Leonard Maboko
1 reference
Christof Geldmacher
1 reference
Britta Wahren
1 reference
Fred Mhalu
1 reference
Sayoki Mfinanga
1 reference
Gunnel Biberfeld
1 reference
Wolfgang Stöhr
1 reference
Merlin L Robb
1 reference
Mary Marovich
1 reference
Charlotta Nilsson
1 reference
Sheena McCormack
1 reference
Arne Kroidl
1 reference
Asli Bauer
1 reference
Muhammad Bakari
1 reference
Patricia J Munseri
1 reference
Agricola Joachim
1 reference
Philipp Mann
1 reference
Candida Moshiro
1 reference
Eligius Lyamuya
1 reference
Marco Missanga
1 reference
Bahati Kaluwa
1 reference
Lilly Podola
1 reference
Karina Godoy-Ramirez
1 reference
Frances Gotch
1 reference
Richard Stout
1 reference
Eric Sandström
1 reference
15 April 2015
1 reference
1 reference
10
1 reference
4
1 reference
e0119629
1 reference
15 April 2015
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference